Document:

Form of Restricted Stock Award Agreement

 Exhibit 10.2 
 Version 1: 
 AMENDMENT TO RESTRICTED STOCK AGREEMENT 
 In accordance with Sections 4.3 and 11.1 of the Unigene Laboratories, Inc. 2006 Stock-Based Incentive Compensation Plan (the “Plan”), the Board of Directors of Unigene Laboratories, Inc. (the
“Company”) hereby amends the 2006 Stock-Based Incentive Compensation Plan Restricted Stock Award Agreement by and between you and the Company, dated as of [June 9, 2008] [June 18, 2008] [December 12, 2008]
[January 23, 2009] (the “Agreement”), effective with respect to the Agreement as of the “Grant Date” set forth therein. Capitalized terms used but not defined herein shall have the meanings set forth in the Agreement.

 In order to ensure that your Restricted Stock is fully and freely transferable once vested, the following provision in the Agreement is hereby deleted:
“Once vested, the Restricted Stock will be transferable, without consideration, to immediate family members (i.e., children, grandchildren or spouse), to trusts for the benefit of such immediate family members and to partnerships in which such
family members are the only partner.” 
 Instead, the Agreement will provide as follows: “Prior to vesting, the Restricted Stock is not
transferable, except, without consideration, to immediate family members (i.e., children, grandchildren or spouse), to trusts for the benefit of such immediate family members and to partnerships in which such family members are the only
partners.” 
 Except as specifically set forth and changed herein, the Agreement is reaffirmed and remains unchanged and in full force and effect.

 Please sign and return a copy of this amendment to the Vice President of Finance indicating your agreement to the terms of this letter. 
 Your signature will acknowledge that this letter reflects our final agreement regarding amendment of your Award (as defined in the Agreement), supersedes any prior
written or oral agreement, understanding or communication otherwise regarding your Award, that you have received and reviewed the Plan, and that you agree to abide by the applicable terms of these documents. 
 Very truly yours, 
  

									
	UNIGENE LABORATORIES, INC.	 		 		 	
					
	By:	 	  
	 		 	Date:	 	  

		 	[                                       
                         ]	 		 		 	
		 	[Title]	 		 		 	
	
	The undersigned hereby agrees to the foregoing:
				
	  
	 		 	 Date:
	 	  

	 [                                        
                                         
   ]
	 		 		 	

 Version 2: 
 AMENDMENT TO RESTRICTED STOCK AGREEMENTS 
 In accordance with Sections 4.3 and 11.1 of the Unigene Laboratories, Inc. 2006 Stock-Based Incentive
Compensation Plan (the “Plan”), the Board of Directors of Unigene Laboratories, Inc. (the “Company”) hereby amends (i) the 2006 Stock-Based Incentive Compensation Plan Restricted Stock Award Agreement by and between you and
the Company, dated as of January 23, 2009 (the “January Agreement”) and (ii) the 2006 Stock-Based Incentive Compensation Plan Restricted Stock Award Agreement by and between you and the Company, dated as of May 1, 2009 (the
“May Agreement” and, together with the January Agreement, the “Agreements” and each an “Agreement”), effective with respect to each particular Agreement as of the “Grant Date” set forth in such Agreement.
Capitalized terms used but not defined herein shall have the meanings set forth in the Agreements. 
 In order to ensure that your Restricted Stock is fully
and freely transferable once vested, the following provision in each Agreement is hereby deleted: “Once vested, the Restricted Stock will be transferable, without consideration, to immediate family members (i.e., children, grandchildren or
spouse), to trusts for the benefit of such immediate family members and to partnerships in which such family members are the only partner.” 
 Instead,
each Agreement will provide as follows: “Prior to vesting, the Restricted Stock is not transferable, except, without consideration, to immediate family members (i.e., children, grandchildren or spouse), to trusts for the benefit of such
immediate family members and to partnerships in which such family members are the only partners.” 
 Except as specifically set forth and changed
herein, each Agreement is reaffirmed and remains unchanged and in full force and effect. 
 Please sign and return a copy of this amendment to the Vice
President of Finance indicating your agreement to the terms of this letter. 
 Your signature will acknowledge that this letter reflects our final agreement
regarding amendment of your Awards (as defined in each Agreement), supersedes any prior written or oral agreement, understanding or communication otherwise regarding your Awards, that you have received and reviewed the Plan, and that you agree to
abide by the applicable terms of these documents. 
 Very truly yours, 
  

									
	UNIGENE LABORATORIES, INC.	 		 		 	
					
	By:	 	  
	 		 	Date:	 	  

		 	[                                       
                         ]	 		 		 	
		 	[Title]	 		 		 	
	
	The undersigned hereby agrees to the foregoing:
				
	  
	 		 	 Date:
	 	  

	 [                                        
                                         
   ]
	 		 		 	

  

 2Amended and Restated 2006 Stock-Based Incentive Compensation Plan

 Exhibit 10.3 
 UNIGENE LABORATORIES, INC. 
 2006 STOCK-BASED INCENTIVE COMPENSATION PLAN 
 Section 1. Purpose of the Plan. The purpose of the Unigene Laboratories, Inc. 2006 Stock-Based Incentive Compensation Plan is to assist the
Company and its Subsidiaries in attracting and retaining valued Employees, Consultants and Non-Employee Directors by offering them a greater stake in the Company’s success and a closer identity with it, and to encourage ownership of the
Company’s stock by such Employees, Consultants and Non-Employee Directors. 
 This Unigene Laboratories, Inc. 2006 Stock-Based Incentive
Compensation Plan (the “Plan”) restates, renames, amends and merges the Unigene Laboratories, Inc. 2000 Stock Option Plan and the Unigene Laboratories, Inc. Directors Stock Option Plan (the “Predecessor Plans”)
effective June 15, 2006. Any awards outstanding under the Predecessor Plans shall continue to be governed by the terms of such Predecessor Plans as in effect prior to the effective date of this Plan. 
 Section 2. Definitions. As used herein, the following definitions shall apply: 
 2.1. “Award” means an award of Deferred Stock, Restricted Stock, Options, SARs, Phantom Stock or other stock-based award under the Plan.

 2.2. “Award Agreement” means the written agreement, instrument or document evidencing an Award. 
 2.3. “Board” means the Board of Directors of the Company. 
 2.4. “Cause” means, 
 (a) if the applicable Participant is party to an effective
employment, consulting, severance or similar agreement with the Company or a Subsidiary, “Cause” shall have the same meaning as such term is defined therein; 
 (b) if the applicable Participant is not a party to an effective employment, consulting, severance or similar agreement or if no definition of “Cause” is set forth in the applicable employment, consulting,
severance or similar agreement, “Cause” shall have the same meaning as such term is defined in the applicable Award Agreement; 
 (c) if neither (a) nor (b) applies, then “Cause” shall mean (i) the Participant’s willful misconduct or gross negligence in connection with the performance of the Participant’s duties for the Company or
its Subsidiaries; (ii) the Participant’s conviction of, or a plea of nolo contendere to, a felony or a crime involving fraud or moral turpitude; (iii) the Participant’s engaging in any business that directly or indirectly
competes with the Company or its Subsidiaries; (iv) disclosure of trade secrets, customer lists or confidential information of the Company, its Subsidiaries or Affiliates to a competitor or unauthorized person; as determined by the Committee in
its sole discretion. 
 2.5. “Change in Control” means, unless otherwise determined by the Committee or provided in an Award
Agreement, 
  

 B-1 

 (a) the acquisition in one or more transactions by any “Person” (as such term is used for
purposes of section 13(d) or section 14(d) of the 1934 Act) but excluding, for this purpose, the Company or its Subsidiaries, any Stockholder of the Company or any employee benefit plan of the Company or its Subsidiaries, of “Beneficial
Ownership” (within the meaning of Rule 13d-3 under the 1934 Act) of thirty-five percent (35%) or more of the combined voting power of the Company’s then outstanding voting securities (the “Voting Securities”); 
 (b) the individuals who, as of the effective date of the Plan, constitute the Board (the “Incumbent Board”) cease for any reason to constitute
at least a majority of the Board; provided, however, that if the election, or nomination for election by the Company’s Stockholders, of any new director was approved by a vote of at least a majority of the Incumbent Board, such new director
shall be considered as a member of the Incumbent Board, and provided further that any reductions in the size of the Board that are instituted voluntarily by the Incumbent Board shall not constitute a Change in Control, and after any such reduction
the “Incumbent Board” shall mean the Board as so reduced; 
 (c) a merger or consolidation involving the Company if the
Stockholders of the Company, immediately before such merger or consolidation, do not own, directly or indirectly, immediately following such merger or consolidation, more than seventy percent (70%) of the combined voting power of the
outstanding Voting Securities of the corporation resulting from such merger or consolidation; 
 (d) a complete liquidation or dissolution
of the Company or a sale or other disposition of all or substantially all of the assets of the Company; or 
 (e) acceptance by Stockholders
of the Company of shares in a share exchange if the Stockholders of the Company immediately before such share exchange, do not own, directly or indirectly, immediately following such share exchange, more than seventy percent (70%) of the
combined voting power of the outstanding Voting Securities of the corporation resulting from such share exchange. 
 2.6.
“Code” means the Internal Revenue Code of 1986, as amended. A reference to any provision of the Code shall include reference to any successor provision of the Code. 
 2.7. “Common Stock” means the common stock of the Company, par value $.01 per share. 
 2.8. “Company” means Unigene Laboratories, Inc., a Delaware corporation, or any successor corporation. 
 2.9. “Committee” means the committee of two or more directors appointed by the Board to administer the Plan under Section 4, each
of whom shall be a “non-employee director” as defined in Rule 16b-3 under the Exchange Act and an “outside director” as defined in Section 162(m) of the Code and the regulations issued thereunder. In the absence of the
appointment of any such Committee, any action permitted or required to be taken hereunder by the Committee shall be deemed to refer to the Board. 
 2.10. “Consultant” means a natural person who provides bona fide services to the Company other than in connection with the offer or sale of securities in a capital-raising transaction and is not engaged in activities that
directly or indirectly promote or maintain a market for the Company’s securities. 
  

 B-2 

 2.11. “Deferred Stock” means an Award made under Section 6.4 of the Plan to receive
Common Stock at the end of a specified Deferral Period. 
 2.12. “Deferral Period” means the period during which the receipt
of Common Stock pursuant to a Deferred Stock Award under Section 6.4 of the Plan will be deferred. 
 2.13.
“Disability” means a “disability” within the meaning of Section 409A of the Code and the regulations and guidance thereunder. 
 2.14. “Employee” means an officer or other employee of the Company or a Subsidiary, including a director who is such an employee. 
 2.15. “Exchange Act” means the Securities Exchange Act of 1934, as amended. A reference to any provision of the Exchange Act or rule
promulgated under the Exchange Act shall include reference to any successor provision or rule. 
 2.16. “Fair Market Value”
means, on any given date (i) if Common Stock is then listed on a national stock exchange, the closing price per share of Common Stock on the exchange for such date, or if no sale was made on such date on the exchange, on the last preceding day
on which a sale occurred; (ii) if Common Stock is not then listed on a national exchange, but is then quoted on NASDAQ or a similar quotation system, the closing price per share of Common Stock as quoted on NASDAQ or a similar quotation system
on such date, or if no sale was made on such date on the exchange, on the last preceding day on which a sale was made; or (iii) if (i) and (ii) do not apply, such value as the Committee in its discretion may in good faith determine in
accordance with Section 409A of the Code (and, with respect to Incentive Stock Options, Section 422 of the Code) and the applicable guidance thereunder. 
 2.17. “Incentive Stock Option” means an Option or portion thereof intended to meet the requirements of an incentive stock option as defined in Section 422 of the Code and designated as an
Incentive Stock Option. 
 2.18. “Non-Employee Director” means a member of the Board who is not an Employee. 
 2.19. “Non-Qualified Option” means an Option or portion thereof not intended to be an Incentive Stock Option, and designated as a
Non-Qualified Option. 
 2.20. “Option” means a right granted under Section 6.1 of the Plan to purchase a specified
number of shares of Common Stock at a specified price. An Option may be an Incentive Option or a Non-Qualified Option. 
 2.21.
“Participant” means any Employee, Non-Employee Director or Consultant who receives an Award. 
 2.22. “Performance
Cycle” means the period selected by the Committee during which the performance of the Company, any Subsidiary, or any department thereof, or any individual is measured for the purpose of determining the extent to which a Performance Goal
has been achieved. 
 2.23. “Performance Goals” means goals established by the Committee in its sole discretion the
attainment of which is substantially uncertain at the time such goals are established. Performance Goals may be described in terms of Company-wide objectives or objectives that are related to the performance of the individual Participant or the
Subsidiary, division, department or 

  

 B-3 

 
function within the Company or Subsidiary in which the Participant is employed. Performance Goals may be measured on an absolute or relative basis. Relative
performance may be measured by a group of peer companies or by a financial market index. Performance Goals may be based upon: specified levels of or increases in the Company’s, a division’s or a Subsidiary’s return on capital, equity
or assets; earnings measures/ratios (on a gross, net, pre-tax or post-tax basis), including diluted earnings per share, total earnings, operating earnings, earnings growth, earnings before interest and taxes (EBIT) and earnings before interest,
taxes, depreciation and amortization (EBITDA); net economic profit (which is operating earnings minus a charge to capital); net income; operating income; sales; sales growth; gross margin; direct margin; share price (including but not limited to
growth measures and total shareholder return), operating profit; per period or cumulative cash flow (including but not limited to operating cash flow and free cash flow) or cash flow return on investment (which equals net cash flow divided by total
capital); inventory turns; financial return ratios; market share; balance sheet measurements such as receivable turnover; improvement in or attainment of expense levels; improvement in or attainment of working capital levels; debt reduction;
strategic innovation, including but not limited to entering into, substantially completing, or receiving payments under, relating to, or deriving from a joint development agreement, licensing agreement, or similar agreement; customer or employee
satisfaction; individual objectives; any other financial or other measurement deemed appropriate by the Committee as it relates to the results of operations or other measurable progress of the Company and Subsidiaries (or any business unit thereof);
and any combination of any of the foregoing criteria. If the Committee determines that a change in the business, operations, corporate structure or capital structure of the Company, or the manner in which it conducts its business, or other events or
circumstances render the Performance Goals unsuitable, the Committee may modify such Performance Goals or the related minimum acceptable level of achievement, in whole or in part, as the Committee deems appropriate and equitable. 
 2.24. “Phantom Stock” means a book-entry unit with a value equal to one share of Common Stock awarded under Section 6.5 of the
Plan. 
 2.25. “Plan” means the Unigene Laboratories, Inc. 2006 Stock-Based Incentive Compensation Plan herein set forth, as
amended from time to time. 
 2.26. “Qualified Performance-Based Award” means an Award or portion of an Award that is
intended to satisfy the requirements for “qualified performance-based compensation” under Section 162(m) of the Code and the regulations issued thereunder. 
 2.27. “Restricted Stock” means Common Stock awarded by the Committee under Section 6.3 of the Plan. 
 2.28. “Restriction Period” means the period during which Restricted Stock awarded under Section 6.3 of the Plan is subject to forfeiture. 
 2.29. “SAR” means a stock appreciation right awarded by the Committee under Section 6.2 of the Plan. 
 2.30. “Subsidiary” means any corporation, partnership, joint venture or other business entity of which 50% or more of the outstanding
voting power is beneficially owned, directly or indirectly, by the Company. 
 2.31. “Ten Percent Shareholder” means a
person who on any given date owns, either directly or indirectly (taking into account the attribution rules contained in Section 424(d) of the Code), stock possessing more than 10% of the total combined voting power of all classes of stock of
the Company or a Subsidiary. 
  

 B-4 

 Section 3. Eligibility. Any Employee, Non-Employee Director or Consultant shall be eligible to
receive an Award; provided, however, that only persons who are employees of the Company or any subsidiary corporation (within the meaning of Section 424(f) of the Code) may be granted Options which are intended to qualify as Incentive Stock
Options. 
 Section 4. Administration and Implementation of Plan. 
 4.1. The Plan shall be administered by the Committee; provided, however, that the Board shall administer and otherwise exercise all powers of the
Committee under the Plan with respect to Awards granted to Non-Employee Directors. Notwithstanding the foregoing, the Committee may make recommendations to the full Board regarding Awards to Non-Employee Directors. Any action of the Committee in
administering the Plan shall be final, conclusive and binding on all persons, including the Company, its Subsidiaries, their employees, Participants, persons claiming rights from or through Participants and stockholders of the Company. 

4.2. Notwithstanding Section 4.1, the Board shall serve as a “Secondary Committee” with the full authority to grant Awards to
eligible individuals who are not subject to the requirements of Rule 16b-3 of the Exchange Act or Section 162(m) of the Code and administer the Plan with respect to such Awards. In all cases requiring an interpretation of the Plan related to an
Award made by the Secondary Committee, the use of the term “Committee” herein shall refer to the Secondary Committee. Notwithstanding the foregoing, the Board may delegate to one or more officers or Board members the authority to act as a
Secondary Committee with the same authority with respect to selecting the individuals to whom Awards are granted and establishing the terms and conditions of such Awards as the Secondary Committee has under the terms of the Plan. 
 4.3. Subject to the provisions of the Plan, the Committee (or, as applicable, the Board) shall have full and final authority in its discretion to
(i) select the Employees, Non-Employee Directors and Consultants who will receive Awards pursuant to the Plan; (ii) determine the type or types of Awards to be granted to each Participant; (iii) determine the number of shares of
Common Stock to which an Award will relate, the terms and conditions of any Award granted under the Plan (including, but not limited to, restrictions as to vesting, transferability or forfeiture, exercisability or settlement of an Award and waivers
or accelerations thereof, and waivers of or modifications to Performance Goals relating to an Award, based in each case on such considerations as the Committee shall determine) and all other matters to be determined in connection with an Award;
(iv) determine whether, to what extent, and under what circumstances an Award may be canceled, forfeited, or surrendered; (v) determine whether, and to certify that, Performance Goals to which the settlement of an Award is subject are
satisfied; (vi) correct any defect or supply any omission or reconcile any inconsistency in the Plan, and adopt, amend and rescind such rules, regulations, guidelines, forms of agreements and instruments relating to the Plan as it may deem
necessary or advisable; and (vii) make all other determinations as it may deem necessary or advisable for the administration of the Plan. 
 Section 5. Shares of Common Stock Subject to the Plan. 
 5.1. Subject to adjustment as provided in Section 10, the
total number of shares of Common Stock available for Awards under the Plan shall be 5,000,000 shares increased by any shares of Common stock that were reserved under the Predecessor Plans but which, as of the effective date of this Plan,
(i) are not subject to grants under such Predecessor Plans, or (ii) are subsequently forfeited, cancelled or expire unexercised under the terms of such Predecessor Plans. 
 5.2. All shares of Common Stock may be issued pursuant to Incentive Stock Options, and no more than 200,000 shares may be awarded to any Employee as a
Qualified 

  

 B-5 

 
Performance-Based Award in any one calendar year. Common Stock awarded under the Plan may be reserved or made available from the Company’s authorized
and unissued Common Stock or from Common Stock reacquired and held in the Company’s treasury. 
 5.3. Any shares of Common Stock issued
by the Company through the assumption or substitution of outstanding grants from an acquired company shall not reduce the shares of Common Stock available for Awards under the Plan. 
 5.4. If any shares subject to an Award under this Plan are forfeited or such Award otherwise terminates or is settled for any reason whatsoever without
an actual distribution of shares to the Participant, any shares counted against the number of shares available for issuance pursuant to the Plan with respect to such Award shall, to the extent of any such forfeiture, settlement, or termination,
again be available for Awards under the Plan; provided, however, that the Committee may adopt procedures for the counting of shares relating to any Award to ensure appropriate counting, avoid double counting, provide for adjustments in any case in
which the number of shares actually distributed differs from the number of shares previously counted in connection with such Award, and if necessary, to comply with applicable law or regulations. 
 Section 6. Awards. Awards may be granted on the terms and conditions set forth in this Section 6. In addition, the Committee may impose on
any Award or the exercise thereof, at the date of grant or thereafter, such additional terms and conditions, not inconsistent with the provisions of the Plan, as the Committee shall determine, including without limitation terms requiring forfeiture
of Awards in the event of the termination of employment or other relationship with the Company or any Subsidiary by the Participant; provided, however, that the Committee shall retain full power to accelerate or waive any such additional term or
condition as it may have previously imposed. The right of a Participant to exercise or receive a grant or settlement of any Award, and the timing thereof, may be subject to such Performance Goals as may be determined by the Committee. All Awards,
and the terms and conditions applicable thereto, shall be evidenced by an Award Agreement. 
 6.1. Options. Options give a Participant
the right to purchase a specified number of shares of Common Stock from the Company for a specified time period at a fixed exercise price. Options may be either Incentive Stock Options or Non-Qualified Stock Options; provided that Incentive Stock
Options may not be granted to Non-Employee Directors or Consultants. The grant of Options shall be subject to the following terms and conditions: 
 (a) Exercise Price. The price per share at which Common Stock may be purchased upon exercise of an Option shall be determined by the Committee, but shall be not less than the Fair Market Value of a share of Common Stock on the date
of grant (110% of Fair Market Value in the case of an Incentive Stock Option granted to a Ten Percent Shareholder). 
 (b) Term of
Options. The term of an Option shall in no event be greater than ten years (five years in the case of an Incentive Stock Option granted to a Ten Percent Shareholder). 
 (c) Exercise of Option. Each Option grant shall specify the time or times at which an Option may be exercised in whole or in part and the terms
and conditions applicable thereto, including (i) a vesting schedule which may be based upon the passage of time, attainment of Performance Goals or a combination thereof, (ii) whether the exercise price for an Option shall be paid in cash,
with shares of Common Stock, with any combination of cash and shares of Common Stock, or with other legal consideration that the Committee may deem appropriate, (iii) the methods of payment, which may include payment by attestation of shares
and through cashless exercise arrangements, to the extent permitted by applicable law, and (iv) the 

  

 B-6 

 
methods by which, or the time or times at which, Common Stock will be delivered or deemed to be delivered to Participants upon the exercise of such Option.
Payment of the exercise price shall in all events be made within three days after the date of exercise of an Option. Unless otherwise determined by the Committee, each Option shall be exercisable for a period of 90 days following termination of
employment other than for Cause and 180 days following the Participant’s death or Disability, to the extent the Option was otherwise exercisable at the time of such termination, death or Disability. Unless otherwise determined by the Committee,
for any other termination of employment, the Option shall not be exercisable following termination of employment. 
 (d) Incentive Stock
Options. Each Participant awarded an Incentive Stock Option under the Plan shall notify the Company in writing immediately after the date he or she makes a disqualifying disposition (as defined in Section 421(b) of the Code) of any shares
of Common Stock acquired pursuant to the exercise of such Incentive Stock Option. The Company may, if determined by the Committee and in accordance with procedures established by it, retain possession of any shares acquired pursuant to the exercise
of an Incentive Stock Option as agent for the applicable Participant until the end of the period described in the preceding sentence, subject to complying with any instructions from such Participant as to the sale of such shares. 
 6.2. Stock Appreciation Rights. A SAR shall confer on the Participant a right to receive, upon exercise thereof, the excess of (A) the Fair
Market Value of one share of Common Stock on the date of exercise over (B) the grant price of the SAR as determined by the Committee, but which may never be less than the Fair Market Value of a share of Common Stock on the date of grant. The
grant of SARs shall be subject to the following terms and conditions: 
 (a) Each SAR grant shall specify the time or times at which a SAR
may be exercised in whole or in part (including vesting upon the passage of time, the attainment of Performance Goals, or a combination thereof), the method of exercise, method of settlement (in cash, Common Stock or a combination thereof), form of
consideration payable in settlement, method by which Common Stock will be delivered or deemed to be delivered to Participants, and any other terms and conditions of any SAR. Unless otherwise determined by the Committee, each SAR shall be exercisable
for a period of 90 days following termination of employment other than for Cause and 180 days following the Participant’s death or Disability, to the extent the SAR was otherwise exercisable at the time of such termination, death or Disability.
Unless otherwise determined by the Committee, for any other termination of employment, the SAR shall not be exercisable following termination of employment. 
 (b) The term of a SAR shall in no event be greater than ten years. 
 6.3. Restricted Stock. An Award
of Restricted Stock is a grant by the Company of a specified number of shares of Common Stock to the Participant, which shares are subject to forfeiture upon the happening of specified events during the Restriction Period. Such an Award shall be
subject to the following terms and conditions: 
 (a) Each Restricted Stock grant shall specify the duration of the Restriction Period
and/or each installment thereof and the conditions under which the Restricted Stock may be forfeited to the Company. Such restrictions may include a vesting schedule based upon the passage of time, the attainment of Performance Goals or a
combination thereof. 
 (b) During the Restriction Period, the transferability of Restricted Stock shall be prohibited or restricted in the
manner and to the extent prescribed in the applicable Award Agreement. Such restrictions may include, without limitation, rights of repurchase or first refusal in the Company or provisions subjecting the Restricted Stock to a continuing substantial
risk of forfeiture in the hands of any transferee. 
  

 B-7 

 (c) Upon determination of the number of shares of Restricted Stock to be granted to the Participant, the
Committee shall direct that a certificate or certificates representing the number of shares of Common Stock be issued to the Participant with the Participant designated as the registered owner. The certificate(s) representing such shares shall be
legended as to sale, transfer, assignment, pledge or other encumbrances during the Restriction Period and deposited by the Participant, together with a stock power endorsed in blank, with the Company, to be held in escrow during the Restriction
Period. At the end of the Restriction Period the restrictions imposed hereunder shall lapse with respect to the number of shares of Restricted Stock as provided in the Award Agreement, and the legend shall be removed and such number of shares
delivered to the Participant (or, where appropriate, the Participant’s legal representative). 
 (d) Unless otherwise provided in the
applicable Award Agreement, during the Restriction Period the Participant shall have all the rights of a stockholder with respect to Restricted Stock, including, without limitation, the right to receive dividends thereon (whether in cash or shares
of Common Stock) and to vote such shares of Restricted Stock. Dividends shall be subject to the same restrictions as the underlying Restricted Stock unless otherwise provided by the Committee. 
 (e) In the sole discretion of the Committee, an Award Agreement regarding Restricted Stock may provide for a tax reimbursement cash payment to be made
by the Company to any Participant in connection with the tax consequences resulting from an Award of Restricted Stock, the lapse of restrictions on any Restricted Stock or the payment by a Participant of any taxes related thereto, subject to such
conditions as the Committee may specify. 
 6.4. Deferred Stock. An Award of Deferred Stock is an agreement by the Company to deliver
to the Participant a specified number of shares of Common Stock at the end of a specified Deferral Period. Such an Award shall be subject to the following terms and conditions: 
 (a) Upon determination of the number of shares of Deferred Stock to be awarded to a Participant, the Committee shall direct that the same be credited to
the Participant’s account on the books of the Company but that issuance and delivery of the same shall be deferred until the date or dates specified in the applicable Award Agreement or until the achievement of any Performance Goals.

 (b) Unless otherwise provided in the applicable Award Agreement, prior to issuance and delivery of the Deferred Stock, the Participant
shall have no rights as a stockholder with respect to any shares of Deferred Stock credited to the Participant’s account. 
 (c)
Amounts equal to any dividends declared during the Deferral Period with respect to the number of shares covered by a Deferred Stock Award will be paid to the Participant currently, or deferred and deemed to be reinvested in additional Deferred
Stock, or otherwise reinvested on such terms as are determined at the time of the Award by the Committee, in its sole discretion, and specified in the Award Agreement. 
 (d) The Deferral Period may provide for distribution in one or more installments. At the end of the Deferral Period or any installment thereof the shares of Deferred Stock applicable to such installment credited to
the account of a Participant shall be issued and delivered to the Participant (or, where appropriate, the Participant’s legal representative) in accordance with the terms of the Award Agreement. 
 6.5. Phantom Stock. A Phantom Stock award shall confer on the Participant the right to receive the Fair Market Value of the Phantom Stock upon the
attainment of Performance Goals or the passage of time as specified by the Committee in an Award Agreement or otherwise. The grant of Phantom Stock shall be subject to the following terms and conditions: 
  

 B-8 

 (a) At the discretion of the Committee, the Participant may receive dividend equivalents in connection
with Phantom Stock which dividend equivalents may be payable in cash or in shares, upon such terms as the Committee, in its sole discretion, deems appropriate. 
 (b) Participants will not have any voting rights with respect to Phantom Stock. 
 (c) Payment of Phantom
Stock shall be made upon the date of attainment of Performance Goals or passage of time as specified in the Award Agreement. Payment may be in the form of cash or Common Stock (or a combination thereof) which has an aggregate Fair Market Value equal
to the Fair Market Value of the Phantom Stock on the payment date. Any Common Stock issued in payment of the applicable Phantom Stock may be subject to such additional restrictions as the Committee deems appropriate. 
 6.6. Other Stock-Based Awards. The Committee is authorized, subject to limitations under applicable law, to grant to Participants any type of
Award other than an Award provided in Section 6.1, 6.2, 6.3, 6.4 or 6.5 hereof that is payable in, or valued in whole or in part by reference to, shares of Common Stock, and that is deemed by the Committee to be consistent with the purposes of
the Plan. Such stock-based Awards may include Awards granted in substitution for any other right of a Participant to receive payment of compensation from the Corporation or a Subsidiary. 
 6.7. Rules Applicable to Qualified Performance-Based Awards. To the extent the Committee determines, in its sole discretion, necessary or
advisable in order to comply with the deductibility limitations of Section 162(m) of the Code applicable to Qualified Performance-Based Awards, the following rules shall apply: 
 (a) Only an Employee who is a “covered employee” within the meaning of Section 162(m) of the Code shall be eligible to receive
Qualified Performance-Based Awards. The Committee shall designate in its sole discretion which covered employees will be Participants for a Performance Cycle within the earlier of the (x) first 90 days of a Performance Cycle and (y) the
lapse of 25% of the Performance Cycle. 
 (b) The Committee shall establish in writing within the earlier of the (x) first 90 days of a
Performance Cycle and (y) the lapse of 25% of the Performance Cycle, and in any event, while the outcome is substantially uncertain, (A) Performance Goals for the Performance Cycle, and (B) in respect of such Performance Goals, a
minimum acceptable level of achievement below which no payment will be made or no Award shall vest or become exercisable, and an objective formula or other method for determining the amount of any payment to be made or the extent to which an Award
hereunder shall vest or become exercisable if performance is at or above such minimum acceptable level but falls short of the maximum achievement of the specified Performance Goals. 
 (c) Following the completion of a Performance Cycle, the Committee shall review and certify in writing whether, and to what extent, the Performance
Goals for the Performance Cycle have been achieved and, if so, to also calculate and certify in writing the amount of the Qualified Performance-Based Awards earned for the period based upon the Performance Goals and the related formulas or methods
as determined pursuant to Section 6.7(b). The Committee shall then determine the actual amount payable or the extent to which an Award is vested or exercisable as a result of attainment of such Performance Goals under each Participant’s

  

 B-9 

 
Award for the Performance Cycle, and, in doing so, may reduce or eliminate, except as otherwise provided in the Award Agreement, the amount of the Award. In
no event shall the Committee have the authority to increase Award amounts to any Covered Employee. 
 (d) An Award granted, vesting or
becoming exercisable with respect to a Performance Cycle shall be paid (unless such Award is subject to the Participant’s exercise, which exercise such Participant has not effectuated) as soon as practicable following completion of the
certification described in Section 6.7(c) but in no event later than December 31 of the year following the end of the Performance Cycle. 
 6.8. Additional Provisions Applicable to Awards. Awards granted under the Plan may, in the discretion of the Committee, be granted either alone or in addition to, in tandem with, or in substitution for, any other Award granted under
the Plan or any award granted under any other plan of the Company or any Subsidiary or any business entity acquired by the Company or any Subsidiary, or any other right of a Participant to receive payment from the Company or any Subsidiary.

 Section 7. Claims Procedure. With respect to Awards of Phantom Stock or Deferred Stock, but only to the extent the Employee
Retirement Income Security Act of 1974, as amended (“ERISA”) is applicable to such an Award or to a Participant, the Company shall administer a claims procedure as follows: 
 7.1. Initial Claim. A Participant or his or her beneficiary who believes that he or she is entitled to benefits under the Plan (the
“Claimant”), or the Claimant’s authorized representative acting on behalf of such Claimant, must make a claim for those benefits by submitting a written notification of his or her claim of right to such benefits. Such
notification must be on the form and in accordance with the procedures established by the Committee. 
 7.2. Procedure for Review. The
Committee shall establish administrative processes and safeguards to ensure that all claims for benefits are reviewed in accordance with the Plan and that, where appropriate, the Plan provisions have been applied consistently to similarly situated
Claimants. Any notification to a Claimant required hereunder may be provided in writing or by electronic media, provided that any electronic notification shall comply with the applicable standards imposed under section 2520.104b-1(c) of Title 29 of
the Code of Federal Regulations. 
 7.3. Claim Denial Procedure. If a claim is wholly or partially denied, the Committee shall notify
the Claimant within a reasonable period of time, but not later than 90 days after receipt of the claim, unless the Committee determines that special circumstances require an extension of time for processing the claim. If the Committee determines
that an extension of time for processing is required, written notice of the extension shall be furnished to the Claimant prior to the termination of the initial 90-day period. In no event shall such extension exceed a period of 180 days from receipt
of the claim. The extension notice shall indicate: (i) the special circumstances necessitating the extension and (ii) the date by which the Committee expects to render a benefit determination. A benefit denial notice shall be written in a
manner calculated to be understood by the Claimant and shall set forth: (i) the specific reason or reasons for the denial, (ii) the specific reference to the Plan provisions on which the denial is based, (iii) a description of any
additional material or information necessary for the Claimant to perfect the claim, with reasons therefor, and (iv) the procedure for reviewing the denial of the claim and the time limits applicable to such procedures, including a statement of
the Claimant’s right to bring a legal action under section 502(a) of ERISA following an adverse benefit determination on review. 
  

 B-10 

 7.4. Appeal Procedure. In the case of an adverse benefit determination, the Claimant or his or her
representative shall have the opportunity to appeal to the Committee for review thereof by requesting such review in writing to the Committee within 60 days of receipt of notification of the denial. Failure to submit a proper application for appeal
within such 60 day period will cause such claim to be permanently denied. The Claimant or his or her representative shall be provided, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information
relevant to the claim. A document, record or other information shall be deemed “relevant” to a claim in accordance with section 2560.503-1(m)(8) of Title 29 of the Code of Federal Regulations. The Claimant or his or her representative
shall also be provided the opportunity to submit written comments, documents, records and other information relating to the claim for benefits. The Committee shall review the appeal taking into account all comments, documents, records and other
information submitted by the Claimant or his or her representative relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination. 
 7.5. Decision on Appeal. The Committee shall notify a Claimant of its decision on appeal within a reasonable period of time, but not later than 60
days after receipt of the Claimant’s request for review, unless the Committee determines that special circumstances require an extension of time for processing the appeal. If the Committee determines that an extension of time for processing is
required, written notice of the extension shall be furnished to the Claimant prior to the termination of the initial 60-day period. In no event shall such extension exceed a period of 60 days from the end of the initial period. The extension notice
shall indicate: (i) the special circumstances necessitating the extension and (ii) the date by which the Committee expects to render a benefit determination. An adverse benefit decision on appeal shall be written in a manner calculated to
be understood by the Claimant and shall set forth: (i) the specific reason or reasons for the adverse determination, (ii) the specific reference to the Plan provisions on which the denial is based, (iii) a statement that the Claimant
is entitled to receive, upon request and free of charge, reasonable access to and copies of all documents, records, and other information relevant to the Claimant’s claim (the relevance of a document, record or other information will be
determined in accordance with section 2560-1(m)(8)) of Title 29 of the Code of Federal Regulations and (iv) a statement of the Claimant’s right to bring a legal action under section 502(a) of ERISA. 
 Section 8. Exchange and Buy Out Provisions. The Committee may at any time exchange or buy out any previously granted Award, or may provide in any
Award Agreement terms and conditions under which the Participant must sell, or offer to sell, to the Company any unexercised Award, whether or not vested, or any Common Stock acquired pursuant to such Award for a payment in cash, Common Stock or
other property based on such terms and conditions as the Committee shall determine and communicate to the Participant at the time that such offer is made or as may be set forth in the Award Agreement. 
 Section 9. Change in Control. Notwithstanding any provision in this Plan to the contrary and unless otherwise provided in the applicable
Participant’s Award Agreement, upon the occurrence of a Change in Control, the following provisions shall apply: 
 9.1. Options and
SARs. Upon a Change in Control, unless otherwise provided by the Committee or in an Award Agreement, the Committee, in its discretion, may take one or more of the following actions with respect to all Options that are outstanding and unexercised
as of such Change in Control: (i) accelerate the vesting and exercisability of all such Options or SARs to the extent unvested and unexercisable, such that all outstanding Options or SARs are fully vested and exercisable, (ii) cancel all
outstanding vested Options or SARs in exchange for a cash payment in an amount equal to the excess, if any, of the Fair Market Value of the Common Stock underlying the unexercised portion of the Option or SAR as of the date of the Change in Control

  

 B-11 

 
over the exercise price of such portion, (iii) terminate all Options or SARs immediately prior to the Change in Control, provided that the Company
provide the Optionee an opportunity to exercise the Option within a specified period following the Optionee’s receipt of a written notice of such Change in Control and of the Company’s intention to terminate the Option prior to such Change
in Control, or (iv) require the successor corporation, following a Change in Control if the Company does not survive such Change in Control, to assume all outstanding Options or SARs and to substitute such Options or SARs with awards involving
the common stock of such successor corporation on terms and conditions necessary to preserve the rights of Optionees or SAR Grantees with respect to such Options or SARs. 
 9.2. Other Awards. Upon a Change in Control, all Awards of Restricted Stock, Phantom Stock, Deferred Stock or other awards granted under Section 6.6., that are outstanding may, at the discretion of the
Committee, become immediately and fully vested. In addition, upon a Change in Control, the Committee may take such other actions as it deems appropriate with respect to the Awards described in the preceding sentence, including the immediate
distribution of amounts that would not otherwise be payable as of the date of the Change in Control. 
 9.3. Committee Authority. The
judgment of the Committee with respect to any matter referred to in this Section 9 shall be conclusive and binding upon each Participant without the need for any amendment to the Plan. 
 Section 10. Adjustments upon Changes in Capitalization. 
 10.1. In the event that the Committee shall determine that any stock dividend, recapitalization, forward split or reverse split, reorganization, merger, consolidation, spin-off, combination, repurchase or share
exchange, extraordinary or unusual cash distribution or other similar corporate transaction or event, affects the Common Stock such that an adjustment is appropriate in order to prevent dilution or enlargement of the rights of Participants under the
Plan, then the Committee shall, in such manner as it may deem equitable, adjust any or all of (i) the number and kind of shares of Common Stock which may thereafter be issued in connection with Awards, (ii) the number and kind of shares of
Common Stock issuable in respect of outstanding Awards, (iii) the aggregate number and kind of shares of Common Stock available under the Plan, (iv) the limits described in Section 5.2 of the Plan, and (v) the exercise or grant
price relating to any Award or, if deemed appropriate, make provision for a cash payment with respect to any outstanding Award; provided, however, in each case, that no adjustment shall be made that would adversely affect the status of any Award
that is intended to be a Qualified Performance-Based Award, unless the Committee expressly determines otherwise. 
 10.2. In addition, the
Committee is authorized to make adjustments in the terms and conditions of, and the criteria included in, Awards, including any Performance Goals, in recognition of unusual or nonrecurring events (including, without limitation, events described in
Section 16.1) affecting the Company or any Subsidiary, or in response to changes in applicable laws, regulations, or accounting principles. Notwithstanding the foregoing, no adjustment shall be made in any outstanding Awards to the extent that
such adjustment would adversely affect the status of an Award intended to be a Qualified Performance-Based Award. 
 Section 11.
Termination and Amendment. 
 11.1. Changes to the Plan and Awards. The Board may amend, alter, suspend, discontinue, or
terminate the Plan without the consent of the Company’s stockholders or Participants, except that any such amendment, alteration, suspension, discontinuation, or termination shall be subject to the approval of the Company’s stockholders if
(i) such action would increase the number of shares subject to the Plan, (ii) decrease the price at which Awards may be 

  

 B-12 

 
granted, or (iii) such stockholder approval is required by any federal or state law or regulation or the rules of any stock exchange or automated
quotation system on which the Common Stock may then be listed or quoted, and the Board may otherwise, in its discretion, determine to submit other such changes to the Plan to the stockholders for approval; provided, however, that without the consent
of an affected Participant, no amendment, alteration, suspension, discontinuation, or termination of the Plan may materially and adversely affect the rights of such Participant under any outstanding Award unless such modification is necessary to
ensure a deduction under Section 162(m) of the Code or to avoid the additional tax described in Section 409A(a)(1)(B) of the Code. 
 11.2. Notwithstanding anything in Section 11.1 to the contrary, any Performance Goal applicable to an Award shall not be deemed a fixed contractual term, but shall remain subject to adjustment by the Committee, in its discretion at any
time in view of the Committee’s assessment of the Company’s strategy, performance of comparable companies, and other circumstances, except to the extent that any such adjustment to a performance condition would adversely affect the status
of an Award intended to be a Qualified Performance-Based Award. 
 Section 12. No Right to Award, Employment or Service. No
Participant shall have any claim to be granted any award under the Plan, and there is no obligation that the terms of Awards be uniform or consistent among Participants. Neither the Plan nor any action taken hereunder shall be construed as giving
any Employee any right to be retained in the employ of the Company or any Subsidiary. For purposes of this Plan, transfer of employment between the Company and its Subsidiaries and affiliates shall not be deemed a termination of employment.

 Section 13. Taxes. Each Participant must make appropriate arrangement for the payment of any taxes relating to an Award granted
hereunder. The Company or any Subsidiary is authorized to withhold from any payment relating to an Award under the Plan, including from a distribution of Common Stock or any payroll or other payment to a Participant amounts of withholding and other
taxes due in connection with any transaction involving an Award, and to take such other action as the Committee may deem advisable to enable the Company and Participants to satisfy obligations for the payment of withholding taxes and other tax
obligations relating to any Award. This authority shall include the ability to withhold or receive Common Stock or other property and to make cash payments in respect thereof in satisfaction of a Participant’s tax obligations. Withholding of
taxes in the form of shares of Common Stock from the profit attributable to the Award shall not occur at a rate that exceeds the minimum required statutory federal and state withholding rates. 
 Section 14. Limits on Transferability; Beneficiaries. No Award or other right or interest of a Participant under the Plan shall be pledged,
encumbered, or hypothecated to, or in favor of, or subject to any lien, obligation, or liability of such Participant to, any party, other than the Company, any Subsidiary or affiliate, or assigned or transferred by such Participant otherwise than by
will or the laws of descent and distribution, and such Awards and rights shall be exercisable during the lifetime of the Participant only by the Participant or his or her guardian or legal representative. Notwithstanding the foregoing, the Committee
may, in its discretion, provide that Awards (other than Incentive Stock Options) or other rights or interests of a Participant granted pursuant to the Plan be transferable, without consideration, to immediate family members (i.e., children,
grandchildren or spouse), to trusts for the benefit of such immediate family members and to partnerships in which such family members are the only partners. The Committee may attach to such transferability feature such terms and conditions as it
deems advisable. In addition, a Participant may, in the manner established by the Committee, designate a beneficiary (which may be a person or a trust) to exercise the rights of the Participant, and to receive any distribution, with respect to any
Award upon the death of the Participant. A beneficiary, guardian, legal representative or other person claiming any rights under the Plan from or through any Participant shall be subject to all terms and conditions of the Plan and any Award
Agreement applicable to such Participant, except as otherwise determined by the Committee, and to any additional restrictions deemed necessary or appropriate by the Committee. 
  

 B-13 

 Section 15. Foreign Nationals. Without amending the Plan, Awards may be granted to Employees or
Consultants who are foreign nationals or render services outside the United States or both, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to further the
purpose of the Plan. 
 Section 16. Securities Law Requirements. 
 16.1. No shares of Common Stock may be issued hereunder if the Company shall at any time determine that (i) the listing upon any securities
exchange, registration or qualification under any state or federal law of any Common Stock otherwise issuable pursuant an Award granted hereunder, or (ii) the consent or approval of any regulatory body or the satisfaction of withholding tax or
other withholding liabilities, is necessary or appropriate in connection with such issuance. In any of the events referred to in clause (i) or clause (ii) above, the issuance of such shares shall be suspended and shall not be effective
unless and until such withholding, listing, registration, qualifications or approval shall have been effected or obtained free of any conditions not acceptable to the Company in its sole discretion, notwithstanding any termination of any Award or
any portion of any Award during the period when issuance has been suspended. 
 16.2. The Committee may require, as a condition to the
issuance of shares hereunder, representations, warranties and agreements to the effect that such shares are being purchased or acquired by the Participant for investment only and without any present intention to sell or otherwise distribute such
shares and that the Participant will not dispose of such shares in transactions which, in the opinion of counsel to the Company, would violate the registration provisions of the Securities Act of 1933, as then amended, and the rules and regulations
thereunder. The certificates issued to evidence such shares shall bear appropriate legends summarizing such restrictions on the disposition thereof. 
 Section 17. Termination. Unless earlier terminated, the Plan shall terminate on the 10-year anniversary of the effective date, and no Awards under the Plan shall thereafter be granted. 
 Section 18. Fractional Shares. The Company will not be required to issue any fractional shares of Common Stock pursuant to the Plan. The Committee
may provide for the elimination of fractions and settlement of such fractional shares of Common Stock in cash. 
 Section 19.
Discretion. In exercising, or declining to exercise, any grant of authority or discretion hereunder, the Committee may consider or ignore such factors or circumstances and may accord such weight to such factors and circumstances as the
Committee alone and in its sole judgment deems appropriate and without regard to the effect such exercise, or declining to exercise such grant of authority or discretion, would have upon the affected Participant, any other Participant, any employee,
the Company, any Subsidiary, any affiliate, any stockholder or any other person. 
 Section 20. Governing Law. The validity and
construction of the Plan and any Award Agreements entered into thereunder shall be construed and enforced in accordance with the laws of the State of Delaware, but without giving effect to the choice of law principles thereof. 
 Section 21. Adoption of the Plan and Effective Date. The Plan shall become effective upon its approval by the stockholders of the Company in
accordance with applicable laws, resolutions or rules governing the applicable securities exchange, and no Award shall become exercisable, realizable or vested prior to such approval. 
  

 B-14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}]]